PGT-A and Age: Why Chromosomal Testing Matters More After 37 — But Isn't a Magic Fix

The Promise — and the Misunderstanding — Around PGT-A

If you've been through IVF consultations recently, you've probably heard the term PGT-A — Preimplantation Genetic Testing for Aneuploidies. It's often presented as a way to give your embryos a "health check" before transfer, weeding out the ones that won't implant or will lead to miscarriage. For many patients, it sounds like exactly the kind of certainty they've been looking for.

But here's the thing: PGT-A is genuinely powerful for some patients and genuinely unnecessary — even counterproductive — for others. Understanding which category you fall into could save you money, time, and emotional heartache. And it starts with understanding what chromosomal abnormalities in embryos actually have to do with your age.

What PGT-A Actually Tests — and Why Chromosomes Matter So Much

Every human embryo should contain exactly 46 chromosomes — 23 pairs. When an embryo has the wrong number (too many or too few), it's called aneuploid. Most aneuploid embryos either fail to implant, result in early miscarriage, or in a small number of cases, lead to chromosomal conditions like Down syndrome.

PGT-A involves biopsying a few cells from a Day 5 or Day 6 blastocyst — typically from the outer layer that will eventually become the placenta — and sending those cells for genetic analysis. The lab can then tell you which embryos are euploid (chromosomally normal) and which are aneuploid, before any transfer takes place.

The goal is straightforward: transfer only the embryos most likely to result in a healthy pregnancy. But the critical question is — how likely are your embryos to be aneuploid in the first place? And that's where age enters the picture in a very significant way.

The Age-Aneuploidy Connection: Why It Isn't Linear — It's a Cliff

Egg quality declines with age, and the primary way this shows up in IVF is through increasing rates of chromosomal abnormality. The numbers are striking:

• Under 35: Roughly 40–50% of blastocysts may be aneuploid
• 35–37: This rises to approximately 50–60%
• 38–40: Around 60–70% of blastocysts are chromosomally abnormal
• Over 40: In many cases, 70–85% or more of embryos are aneuploid

What this means in practice is that a 42-year-old woman who produces four blastocysts may statistically have only one — or even zero — that are euploid. Without PGT-A, transferring those embryos becomes a process of elimination through failed cycles and miscarriages. With PGT-A, you potentially skip that painful trial-and-error and transfer only what has the best chance of working.

For patients over 37, especially those who have experienced recurrent miscarriage or failed transfers, PGT-A shifts from being an optional add-on to a genuinely strategic tool.

But Here's Where It Gets More Complicated

PGT-A is not without its debates — and any honest fertility specialist will tell you that.

The biopsy samples only part of the embryo

The cells tested come from the trophectoderm — the outer layer — not the inner cell mass that becomes the baby. This means there's a phenomenon called mosaicism, where some cells in an embryo are chromosomally normal and others aren't. An embryo labelled aneuploid by PGT-A isn't always uniformly abnormal throughout — and some mosaic embryos have resulted in healthy pregnancies when transferred.

It can reduce your available embryos significantly

For younger women with many blastocysts, losing a few to aneuploid results may not matter much. But for a woman over 40 who produced only two or three blastocysts, being told all are aneuploid can feel — and sometimes is — the end of the road with her own eggs. In some cases, transferring an untested embryo might have been the better gamble.

It doesn't guarantee a successful pregnancy

A euploid embryo still needs a receptive uterine lining, optimal timing, and a degree of biological luck. PGT-A improves the odds per transfer — it doesn't eliminate the possibility of failure.

This is why at Iswarya Fertility, our approach to recommending PGT-A is never one-size-fits-all. It's a conversation that takes into account your age, your embryo numbers, your history, and your specific goals — not a checkbox that gets ticked for every patient walking through the door.

Who Genuinely Benefits Most from PGT-A?

Based on current clinical evidence, PGT-A tends to offer the clearest benefits for:

• Women aged 37 and above, particularly those approaching or past 40
• Patients with a history of two or more miscarriages with no other identified cause
• Those who have experienced recurrent implantation failure (multiple failed transfers despite good-looking embryos)
• Couples where a chromosomal carrier status in one partner increases the risk of aneuploid embryos
• Patients who want to reduce the number of transfer cycles and prefer a single high-confidence transfer over multiple attempts

For women under 35 with good ovarian reserve and no history of miscarriage or failed cycles, the data supporting routine PGT-A is less compelling. In this group, a significant proportion of embryos are already euploid, and the cost and biopsy risk may outweigh the benefit.

What the Testing Process Actually Involves

If your doctor recommends PGT-A, here's what to expect practically:

1. Your embryos are cultured to Day 5 or Day 6 blastocyst stage — only embryos that reach this stage can be biopsied
2. A few cells are removed from the outer layer of each blastocyst
3. The embryos are vitrified (frozen) while results are awaited — typically 1–2 weeks
4. Results classify each embryo as euploid, aneuploid, or mosaic
5. A frozen embryo transfer is planned using the euploid embryo(s)

It's worth noting that the freezing process itself is now highly refined — vitrification survival rates are excellent, and frozen euploid transfers consistently perform as well as, and in many cases better than, fresh transfers.

Having an Honest Conversation with Your Fertility Team

The most important thing to understand about PGT-A is that it's a tool, not a guarantee — and its value depends entirely on your individual circumstances. A good fertility team will be transparent about both when it helps and when it may not be worth the additional cost and complexity for you specifically.

At Iswarya Fertility, our specialists take the time to walk you through your embryo development results, explain what your specific aneuploidy risk looks like based on your age and history, and help you make an informed decision about whether PGT-A belongs in your protocol. If you're over 37, have experienced repeated losses, or simply want to understand whether genetic testing makes sense in your situation, we encourage you to ask — directly and specifically.

The goal is always the same: the right embryo, transferred at the right time, into the best possible environment. PGT-A, when used thoughtfully, is one important way to get there. Book a consultation with Iswarya Fertility today to discuss whether it's right for you.

Frequently Asked Questions

At what age does PGT-A become strongly recommended during IVF?

Most fertility specialists consider PGT-A particularly valuable from age 37 onwards, when the rate of chromosomally abnormal embryos rises significantly. By age 40 and beyond, the majority of blastocysts are aneuploid, making testing an especially strategic choice to avoid unnecessary failed transfers.

Can a PGT-A aneuploid embryo ever result in a healthy baby?

Rarely, yes — particularly in cases of mosaicism, where only some cells in the embryo are abnormal. Some mosaic embryos have resulted in healthy pregnancies, which is why mosaic embryos are not automatically discarded but assessed case by case with your specialist.

Does PGT-A testing harm the embryo?

The biopsy procedure is performed by highly skilled embryologists and current evidence suggests it does not significantly harm embryo viability when done correctly. Embryos are frozen immediately after biopsy, and modern vitrification techniques preserve them very effectively.

If all my embryos test aneuploid, does that mean I can never have a baby with my own eggs?

Not necessarily, though it does indicate a significant challenge. Your specialist may recommend another stimulation cycle to create more embryos, discuss the possibility of transferring mosaic embryos, or talk through donor egg options — all depending on your specific situation and priorities.

Is PGT-A the same as PGT-M or PGT-SR?

No — these are different tests. PGT-A screens for random chromosomal number errors (aneuploidies), while PGT-M tests for specific inherited single-gene disorders, and PGT-SR checks for structural chromosomal rearrangements. Your doctor will recommend the right type based on your medical history.